4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-002541
CEO bought 39,105 shares at an average $0.75 ($29,460)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna CEO | 2025-03-14 | Purchase | +29,999 | $0.75 | $22,631 | 1,294,774 | D |
| Vaddi Krishna CEO | 2025-03-17 | Purchase | +9,106 | $0.75 | $6,829 | 1,303,880 | D |
| Open-market purchases · 39,105 sh · avg $0.75 · $29,460 | |||||||
Loading xslF345X05/primarydocument.xml…